Trends in cardiovascular burden and mortality among adults with prediabetes in the US, 1999-2018.

IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Yi Zhang, Ruodi Lu, Jian Wang, Xingjian Zhang, Xiao Ma
{"title":"Trends in cardiovascular burden and mortality among adults with prediabetes in the US, 1999-2018.","authors":"Yi Zhang,&nbsp;Ruodi Lu,&nbsp;Jian Wang,&nbsp;Xingjian Zhang,&nbsp;Xiao Ma","doi":"10.1177/14791641231188704","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Trends in cardiovascular disease (CVD) risk factors and mortality have been reported among US adults with diabetes, but not among those with prediabetes. This study aimed to examine and compare the trends in CVD risk factors and mortality in US adults with diabetes and prediabetes.</p><p><strong>Methods: </strong>In this serial, cross-sectional study, medical records of prediabetic patients from the National Health and Nutrition Examination Survey (NHANES) among adults aged 18 years or older were retrospectively reviewed.</p><p><strong>Results: </strong>Data on 17,193 individuals including 7803 with diabetes and 9390 with prediabetes were analyzed from 1999-2000 to 2017-2018. A similar non-linear trend in the mean blood pressure (<i>p</i> = .991) and plasma fasting glucose (<i>p</i> = .068) was observed among the population with diabetes and prediabetes. The mean hemoglobin A1c decreased from 7.5% to 7.1% in diabetes and the trend was different from that in prediabetes (<i>p</i> = .004). Among both groups, a significant decline in the mean total cholesterol was identified while there was a difference in the trend (<i>p</i> = .003). The prevalence of hypertension remained largely the same for diabetes and it declined from 59.8% to 48.8% for prediabetes (<i>p</i> = .044). The prevalence of dyslipidemia increased from 40.4% to 53.5% in diabetes and it remained stable for prediabetes. The all-cause mortality decreased from 148.2 to 93.6 per 10,000 person-years between 1999-2006 and 2007-2014 in prediabetes and heart diseases mortality remained unchanged.</p><p><strong>Conclusion: </strong>In the US from 1999 to 2018, the adults with prediabetes had different secular trends in the mean hemoglobin A1c and the prevalence of hypertension and dyslipidemia compared to those with diabetes. There was a significant reduction in all-cause mortality from 1999 to 2014 for the population with prediabetes. However, heart diseases mortality remained stable among them.</p>","PeriodicalId":11092,"journal":{"name":"Diabetes & Vascular Disease Research","volume":"20 4","pages":"14791641231188704"},"PeriodicalIF":2.8000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/55/10.1177_14791641231188704.PMC10408320.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes & Vascular Disease Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/14791641231188704","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Trends in cardiovascular disease (CVD) risk factors and mortality have been reported among US adults with diabetes, but not among those with prediabetes. This study aimed to examine and compare the trends in CVD risk factors and mortality in US adults with diabetes and prediabetes.

Methods: In this serial, cross-sectional study, medical records of prediabetic patients from the National Health and Nutrition Examination Survey (NHANES) among adults aged 18 years or older were retrospectively reviewed.

Results: Data on 17,193 individuals including 7803 with diabetes and 9390 with prediabetes were analyzed from 1999-2000 to 2017-2018. A similar non-linear trend in the mean blood pressure (p = .991) and plasma fasting glucose (p = .068) was observed among the population with diabetes and prediabetes. The mean hemoglobin A1c decreased from 7.5% to 7.1% in diabetes and the trend was different from that in prediabetes (p = .004). Among both groups, a significant decline in the mean total cholesterol was identified while there was a difference in the trend (p = .003). The prevalence of hypertension remained largely the same for diabetes and it declined from 59.8% to 48.8% for prediabetes (p = .044). The prevalence of dyslipidemia increased from 40.4% to 53.5% in diabetes and it remained stable for prediabetes. The all-cause mortality decreased from 148.2 to 93.6 per 10,000 person-years between 1999-2006 and 2007-2014 in prediabetes and heart diseases mortality remained unchanged.

Conclusion: In the US from 1999 to 2018, the adults with prediabetes had different secular trends in the mean hemoglobin A1c and the prevalence of hypertension and dyslipidemia compared to those with diabetes. There was a significant reduction in all-cause mortality from 1999 to 2014 for the population with prediabetes. However, heart diseases mortality remained stable among them.

Abstract Image

Abstract Image

Abstract Image

1999-2018年美国糖尿病前期成年人心血管负担和死亡率趋势。
背景:心血管疾病(CVD)危险因素和死亡率的趋势在美国糖尿病成年人中有报道,但在糖尿病前期人群中没有。本研究旨在检查和比较美国糖尿病和糖尿病前期成年人心血管疾病危险因素和死亡率的趋势。方法:在这项系列的横断面研究中,回顾性回顾了来自国家健康和营养检查调查(NHANES)的18岁或以上成年人糖尿病前期患者的医疗记录。结果:分析了1999-2000年至2017-2018年间17193名患者的数据,其中7803名糖尿病患者和9390名糖尿病前期患者。在糖尿病和糖尿病前期人群中,平均血压(p=.991)和血浆空腹血糖(p=.068)也出现了类似的非线性趋势。糖尿病患者的平均血红蛋白A1c从7.5%下降到7.1%,其趋势与糖尿病前期患者不同(p=0.004),平均总胆固醇显著下降,但趋势存在差异(p=.003)。糖尿病患者的高血压患病率基本保持不变,糖尿病前期患者的高血压发病率从59.8%下降到48.8%(p=.044)。糖尿病的血脂异常患病率从40.4%上升到53.5%,糖尿病前期高血压患病率保持稳定。1999-2006年至2007-2014年间,糖尿病前期的全因死亡率从148.2‰降至93.6‰,心脏病死亡率保持不变。结论:1999年至2018年,在美国,与糖尿病患者相比,糖尿病前期患者的平均血红蛋白A1c以及高血压和血脂异常的患病率有不同的长期趋势。从1999年到2014年,糖尿病前期人群的全因死亡率显著下降。然而,其中心脏病死亡率保持稳定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes & Vascular Disease Research
Diabetes & Vascular Disease Research ENDOCRINOLOGY & METABOLISM-PERIPHERAL VASCULAR DISEASE
CiteScore
4.40
自引率
0.00%
发文量
33
审稿时长
>12 weeks
期刊介绍: Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title. The journal publishes original papers, research letters and reviews. This journal is a member of the Committee on Publication Ethics (COPE)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信